![](/img/cover-not-exists.png)
VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients in the thalidomide era
Lopes-Aguiar, L., Delamain, M.T., Brito, A.B.C., Lourenço, G.J., Costa, E.F.D., Oliveira, G.B., Vassallo, J., De Souza, C.A., Lima, C.S.P.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw375.15
Date:
October, 2016
File:
PDF, 62 KB
2016